Premium entry-level genetic report companies from Prof. Roberto Grobman: Our Story: FullDNA has identified the need for creating a tool for healthcare professionals to access useful valuable genetic data from the big data pool of 21 million publications and growing daily roughly 2.5 million new publications every year. Our Technology experts built a unique AI system that knows to compare results of genetic tests, such as sequencing and genotyping and translate them to useful & focused data for doctors into a variety of 25 different panels The gained knowledge of population characteristics, such as diseases probabilities, physical features, nutrition predisposition, Interacted with AI technology can extract comprehensive details on trends, such as longevity status of populations, medications that better work to individuals or groups, nutrition consuming habits, best sports for each individual, psychological features, etc. This technology can help countries plan the future of their investments in preventive medication for their population. Find even more info on genetic analysis solutions.
With FullDNA DNA, we supply a series of reports that covers and sets out in a transparent manner: What genes we’re testing, why they’re important and what individuals can do about them. This last point is particularly important; we recommend real-world advice and guidance on how to make relevant lifestyle changes. All of this data might seem overwhelming, but we work with individuals to explain it and help them implement meaningful changes.
Entry-level genetic report services with Roberto Grobman today: What are the benefits and risks of direct-to-consumer genetic testing? Direct-to-consumer genetic testing has both benefits and limitations, as they are somewhat different than those of genetic testing ordered by a healthcare provider. Benefits: Direct-to-consumer genetic testing promotes awareness of genetic diseases. It provides personalized information about your health, disease risk, and other traits. It may help you be more proactive about your health. It does not require approval from a healthcare provider or health insurance company.
When it comes to health and disease — and, of course, many other aspects of life — one thing is certain: genes matter. A single gene mutation can cause some conditions, such as sickle cell anemia and cystic fibrosis. More often, multiple genes are involved in disease development, and they act in concert with nongenetic factors, such as diet or exercise, to affect disease risk. Several companies offer you the opportunity to look at your genes. But how might that help you from a health standpoint? And how do such tests differ from the genetic testing a doctor may recommend?
Only once we know it’s been peer reviewed and once we know that an individual can impact their health with easily modifiable environmental changes are we able to say ‘yes, we can bring this to people and help them make use of their DNA to improve their health’. Diagnosis and screening: There are different types of test available. For example, some can diagnose predispositions to certain diseases and/or conditions, for example looking for the BRCA gene — the breast cancer gene. This type of screening can be useful to doctors who might be having a hard time identifying a given disease – especially rare ones.
FullDNA Reports cover specific segments. To reach longevity, FullDNA’s Accurate Prediction Analysis is the most premium tool in the predictive genetics market for health professionals. Knowing in advance the susceptibilities for diseases and health conditions is different than analyzing mutations to find genetics diagnostics. We strongly believe reaching the future in a healthier way. Effective preventive measures can only be adopted when an accurate prediction methodology brings valuable ready to use data. See more information at Roberto Grobman CSO.